An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by ...

Amgen's Repatha lowered first heart attacks and strokes by 36% in a major trial, suggesting PCSK9 drugs may prevent acute ...

Is the risk of a colonoscopy under these circumstances greater than the risk of my getting colon cancer due to Lynch syndrome ...

The cholesterol-lowering medication alirocumab, a PCSK9 inhibitor, along with a statin, lowered LDL cholesterol levels more than 50% in patients after a heart transplant, compared to those taking a ...

I have always been told that colonoscopies are necessary to prevent cancerous polyps from occurring. Is the risk of a colonoscopy under these circumstances greater than the risk of my getting colon ...

I am a 79-year-old female who is currently on biannual infusions for osteoporosis and high cholesterol. In 2018, I was diagnosed with Lynch syndrome with an MSH6 ...

I am a 79-year-old female who is currently on biannual infusions for osteoporosis and high cholesterol. In 2018, I was ...

Adding the PCSK9 inhibitor evolocumab to standard lipid-lowering therapy significantly reduced first major cardiovascular ...

Learn which widely prescribed cholesterol medication has been recalled and how to check if your prescription is affected.

Despite President Trump’s claims, scientists don’t have enough evidence to say acetaminophen use during pregnancy is linked ...